- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Oligomeric tau-targeted immunotherapy in Tg4510 mice ; volume:9 ; number:1 ; day:27 ; month:6 ; year:2017 ; pages:1-15 ; date:12.2017
Alzheimer's research & therapy ; 9, Heft 1 (27.6.2017), 1-15, 12.2017
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Schroeder, Sulana
- Beteiligte Personen und Organisationen
-
Joly-Amado, Aurelie
Soliman, Ahlam
Sengupta, Urmi
Kayed, Rakiz
Gordon, Marcia N.
Morgan, David
SpringerLink (Online service)
- DOI
-
10.1186/s13195-017-0274-6
- URN
-
urn:nbn:de:1111-201709224159
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schroeder, Sulana
- Joly-Amado, Aurelie
- Soliman, Ahlam
- Sengupta, Urmi
- Kayed, Rakiz
- Gordon, Marcia N.
- Morgan, David
- SpringerLink (Online service)
Ähnliche Objekte (12)
Characterization of tau oligomeric seeds in progressive supranuclear palsy
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes
Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
Tau immunotherapy is associated with glial responses in FTLD-tau
BCMA-targeted immunotherapy for multiple myeloma
Circadian disruption promotes the neurotoxicity of oligomeric alpha-synuclein in mice
Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Tag-free semisynthetic tau proteins and novel antibodies targeted against phospho-tau
Targeted Therapy and Immunotherapy for Melanoma in Japan
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Characterization of tau oligomeric seeds in progressive supranuclear palsy
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes
Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
Tau immunotherapy is associated with glial responses in FTLD-tau
BCMA-targeted immunotherapy for multiple myeloma
Circadian disruption promotes the neurotoxicity of oligomeric alpha-synuclein in mice
Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Tag-free semisynthetic tau proteins and novel antibodies targeted against phospho-tau
Targeted Therapy and Immunotherapy for Melanoma in Japan
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Characterization of tau oligomeric seeds in progressive supranuclear palsy
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes
Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
Tau immunotherapy is associated with glial responses in FTLD-tau
BCMA-targeted immunotherapy for multiple myeloma
Circadian disruption promotes the neurotoxicity of oligomeric alpha-synuclein in mice
Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Tag-free semisynthetic tau proteins and novel antibodies targeted against phospho-tau
Targeted Therapy and Immunotherapy for Melanoma in Japan